Blog

• Worried About a Fading Rally? Consider These 3 Dividend Stocks

T. Rowe Price Group (NASDAQ:TROW) held its 2026 annual meeting of stockholders virtually, with Chair, CEO and President Robert Sharps

Xeris Biopharma (NASDAQ:XERS) reported a sharp increase in first-quarter 2026 revenue and raised the low end of its full-year revenue outlook, citing strong demand for RECORLEV and continued

• Bristol Myers Squibb’s big buys: $18.1 billion in 2 biotech deals

Xenon Pharmaceuticals (NASDAQ:XENE) said it is preparing to submit a new drug application to the U.S. Food and Drug Administration

• Caesars Surges on Buyout Buzz. Should Investors Take the Bet?

Wynn Resorts (NASDAQ:WYNN) executives said the casino operator delivered strong first-quarter results across Las Vegas and Macau while

• 3 "Tollbooth" Stocks With Hidden Monopolies in Their Industries

WW International (NASDAQ:WW), operator of WeightWatchers, reaffirmed its 2026 financial outlook after reporting first-quarter results

• Is 2026 The Year to Load Up on Crypto Miners?

TeraWulf (NASDAQ:WULF) said its first-quarter 2026 results reflected a business shifting from Bitcoin mining toward contracted high-performance

• Small-Cap Titans: 3 Russell 2000 Winners for 2025

WillScot (NASDAQ:WSC) reported first-quarter 2026 results that management said exceeded its expectations, as stronger large-project activity and

• Big 3 Music Giant Warner: Streaming Boom Sends Shares Higher

Warner Music Group (NASDAQ:WMG) reported stronger fiscal second-quarter results, with executives saying the company’s growth strategy is

• 3 Companies Quietly Essential to Data Center and AI Operations

Willdan Group (NASDAQ:WLDN) reported a stronger-than-expected start to fiscal 2026, with executives citing margin expansion, improved

• 3 ETFs to Avoid as Oil Shock Hits Markets

Thomson Reuters (NASDAQ:TRI) executives said the company is positioned to benefit from rising compliance complexity and demand for specialized artificial

WhiteHorse Finance (NASDAQ:WHF) reported lower first-quarter earnings and a decline in net asset value as previously identified credit issues weighed on results, while management said share

• MarketBeat Week in Review: 12/11 - 12/15

Westrock Coffee (NASDAQ:WEST) reported sharply higher first-quarter 2026 results, with management saying the company has moved beyond a multiyear investment

• 3 Bargain-Cheap Small Caps Worth a Second Look

Wendy's (NASDAQ:WEN) reported first-quarter results that management said were largely in line with expectations, while acknowledging the restaurant

• Egg Prices Surge: 3 Stocks Set to Benefit from Rising PPI Trends

Vital Farms (NASDAQ:VITL) executives said the company’s first-quarter results and early second-quarter scanner data fell short of

Varex Imaging (NASDAQ:VREX) reported fiscal second-quarter revenue within its guidance range and said demand remained solid across its medical and industrial businesses, while management

Verastem (NASDAQ:VSTM) reported first-quarter 2026 net product revenue of $18.7 million for AVMAPKI FAKZYNJA CO-PACK, as management said the launch of the therapy for KRAS-mutated recurrent

• Tax Software Specialist Vertex In Buy Zone After Base Breakout

Vertex (NASDAQ:VERX) reported first-quarter 2026 results above its guidance range and raised its full-year profitability outlook as

• Vertex Pharmaceuticals Hits Record High on Strong Q1 Earnings

Entrada Therapeutics (NASDAQ:TRDA) said initial data from the first cohort of its phase I/II ELEVATE-44-201 trial showed favorable

• 5 medical stocks growing earnings by triple digits

Vericel (NASDAQ:VCEL) reported record first-quarter revenue and raised its full-year 2026 outlook, citing strong growth across its MACI cartilage

Victory Capital (NASDAQ:VCTR) reported record first-quarter 2026 results, with executives pointing to higher gross flows, the contribution from the Pioneer acquisition and continued growth in its

• MarketBeat Week in Review – 12/15 - 12/19

Upwork (NASDAQ:UPWK) said first-quarter 2026 results reflected a sharp shift in demand late in the period, as macroeconomic uncertainty and faster adoption

• 2026 Food Inflation Outlook: This ETF Could Outperform

Texas Roadhouse (NASDAQ:TXRH) executives said the company opened 2026 with strong sales and traffic gains, as first-quarter revenue surpassed

TWFG (NASDAQ:TWFG) reported double-digit revenue and premium growth for the first quarter of 2026, with management pointing to acquisition contributions, organic growth and margin expansion from

• Strategic Buy Lights Up This Biotech Stock: Time to Invest?

10x Genomics (NASDAQ:TXG) reported a first-quarter revenue increase excluding prior-year settlement revenue and used its earnings call to

Ultralife (NASDAQ:ULBI) reported a first-quarter loss for fiscal 2026 as lower sales, production disruptions and higher one-time costs weighed on results, even as management pointed to a record